FindTrial
Sign In

Reddish skin rash caused by pain medication Etoricoxib

A possible case of Etoricoxib- Induced Fixed Drug Eruption

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/11/016258
Enrollment
1
Registered
2018-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Etoricoxib: Etoricoxib compared to other NSAIDs of same group like Celecoxib

Sponsors

Dr Apoorva
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 50 yr old male patient with complain of fixed drug eruption due to tab Etoricoxib

Exclusion criteria

Exclusion criteria: nil

Design outcomes

Primary

MeasureTime frame
Adverse drug reaction due to etoricoxibTimepoint: within 24 hrs—

Secondary

MeasureTime frame
NilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Apoorva

Kempegowda Institute of medical Sciences

drgirish_k@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026